vs
Side-by-side financial comparison of KOSS CORP (KOSS) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Sensus Healthcare, Inc. is the larger business by last-quarter revenue ($4.9M vs $2.9M, roughly 1.7× KOSS CORP). KOSS CORP runs the higher net margin — -19.8% vs -64.1%, a 44.4% gap on every dollar of revenue. On growth, KOSS CORP posted the faster year-over-year revenue change (-19.6% vs -62.2%). KOSS CORP produced more free cash flow last quarter ($-1.1M vs $-2.4M). Over the past eight quarters, KOSS CORP's revenue compounded faster (4.2% CAGR vs -31.9%).
Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
KOSS vs SRTS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.9M | $4.9M |
| Net Profit | $-565.4K | $-3.2M |
| Gross Margin | 29.0% | 38.4% |
| Operating Margin | -35.5% | -63.8% |
| Net Margin | -19.8% | -64.1% |
| Revenue YoY | -19.6% | -62.2% |
| Net Profit YoY | -700.6% | -304.9% |
| EPS (diluted) | $-0.06 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.9M | $4.9M | ||
| Q3 25 | $4.1M | $6.9M | ||
| Q2 25 | $3.1M | $7.3M | ||
| Q1 25 | $2.8M | $8.3M | ||
| Q4 24 | $3.6M | $13.1M | ||
| Q3 24 | $3.2M | $8.8M | ||
| Q2 24 | $2.9M | $9.2M | ||
| Q1 24 | $2.6M | $10.7M |
| Q4 25 | $-565.4K | $-3.2M | ||
| Q3 25 | $243.7K | $-943.0K | ||
| Q2 25 | $-232.7K | $-1.0M | ||
| Q1 25 | $-316.7K | $-2.6M | ||
| Q4 24 | $94.1K | $1.5M | ||
| Q3 24 | $-419.5K | $1.2M | ||
| Q2 24 | $-110.4K | $1.6M | ||
| Q1 24 | $-313.8K | $2.3M |
| Q4 25 | 29.0% | 38.4% | ||
| Q3 25 | 40.0% | 39.4% | ||
| Q2 25 | 36.0% | 39.7% | ||
| Q1 25 | 39.0% | 52.2% | ||
| Q4 24 | 39.5% | 54.4% | ||
| Q3 24 | 36.6% | 59.3% | ||
| Q2 24 | 40.4% | 58.7% | ||
| Q1 24 | 31.9% | 62.5% |
| Q4 25 | -35.5% | -63.8% | ||
| Q3 25 | -1.1% | -37.3% | ||
| Q2 25 | -14.2% | -26.6% | ||
| Q1 25 | -18.7% | -31.7% | ||
| Q4 24 | -4.0% | 13.2% | ||
| Q3 24 | -19.9% | 16.9% | ||
| Q2 24 | -11.0% | 21.5% | ||
| Q1 24 | -23.1% | 27.1% |
| Q4 25 | -19.8% | -64.1% | ||
| Q3 25 | 6.0% | -13.7% | ||
| Q2 25 | -7.5% | -14.2% | ||
| Q1 25 | -11.4% | -30.8% | ||
| Q4 24 | 2.6% | 11.8% | ||
| Q3 24 | -13.1% | 13.7% | ||
| Q2 24 | -3.8% | 17.4% | ||
| Q1 24 | -11.9% | 21.3% |
| Q4 25 | $-0.06 | $-0.19 | ||
| Q3 25 | $0.03 | $-0.06 | ||
| Q2 25 | $-0.02 | $-0.06 | ||
| Q1 25 | $-0.03 | $-0.16 | ||
| Q4 24 | $0.01 | $0.10 | ||
| Q3 24 | $-0.05 | $0.07 | ||
| Q2 24 | $-0.01 | $0.10 | ||
| Q1 24 | $-0.03 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $30.3M | $48.1M |
| Total Assets | $36.8M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.5M | $22.1M | ||
| Q3 25 | $16.5M | $24.5M | ||
| Q2 25 | $15.7M | $22.2M | ||
| Q1 25 | $13.0M | $19.1M | ||
| Q4 24 | $9.7M | $22.1M | ||
| Q3 24 | $11.9M | $22.6M | ||
| Q2 24 | $14.9M | $19.0M | ||
| Q1 24 | $9.9M | $14.7M |
| Q4 25 | $30.3M | $48.1M | ||
| Q3 25 | $30.9M | $51.2M | ||
| Q2 25 | $30.6M | $52.1M | ||
| Q1 25 | $30.7M | $53.0M | ||
| Q4 24 | $31.0M | $55.8M | ||
| Q3 24 | $30.8M | $54.1M | ||
| Q2 24 | $31.1M | $52.9M | ||
| Q1 24 | $31.1M | $51.2M |
| Q4 25 | $36.8M | $53.0M | ||
| Q3 25 | $37.7M | $58.3M | ||
| Q2 25 | $37.2M | $58.9M | ||
| Q1 25 | $37.3M | $60.2M | ||
| Q4 24 | $37.4M | $62.2M | ||
| Q3 24 | $38.1M | $59.9M | ||
| Q2 24 | $37.2M | $58.2M | ||
| Q1 24 | $37.6M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-760.8K | $-2.2M |
| Free Cash FlowOCF − Capex | $-1.1M | $-2.4M |
| FCF MarginFCF / Revenue | -37.5% | -47.9% |
| Capex IntensityCapex / Revenue | 10.9% | 3.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-546.7K | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-760.8K | $-2.2M | ||
| Q3 25 | $762.6K | $2.3M | ||
| Q2 25 | $-534.9K | $3.1M | ||
| Q1 25 | $370.4K | $-2.7M | ||
| Q4 24 | $-252.0K | $-827.0K | ||
| Q3 24 | $201.6K | $4.0M | ||
| Q2 24 | $-174.0K | $4.2M | ||
| Q1 24 | $328.6K | $-8.2M |
| Q4 25 | $-1.1M | $-2.4M | ||
| Q3 25 | $761.5K | $2.3M | ||
| Q2 25 | $-541.8K | $3.1M | ||
| Q1 25 | $306.2K | $-2.7M | ||
| Q4 24 | $-314.3K | $-1.1M | ||
| Q3 24 | $-155.6K | $3.6M | ||
| Q2 24 | $-174.8K | $4.2M | ||
| Q1 24 | $269.3K | $-8.4M |
| Q4 25 | -37.5% | -47.9% | ||
| Q3 25 | 18.7% | 33.3% | ||
| Q2 25 | -17.6% | 42.2% | ||
| Q1 25 | 11.0% | -32.2% | ||
| Q4 24 | -8.8% | -8.6% | ||
| Q3 24 | -4.9% | 40.9% | ||
| Q2 24 | -6.0% | 45.8% | ||
| Q1 24 | 10.2% | -79.0% |
| Q4 25 | 10.9% | 3.2% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.2% | 0.4% | ||
| Q1 25 | 2.3% | 0.1% | ||
| Q4 24 | 1.8% | 2.3% | ||
| Q3 24 | 11.2% | 3.8% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 2.3% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | 3.13× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.68× | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KOSS
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
